Company Snapshot: EMIS  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Emisphere Technologies Inc. Presentation at the Bank of America Securities Health Care Conference to Be Webcast

    TARRYTOWN, N.Y., May 16 /PRNewswire-FirstCall/ -- Emisphere Technologies,
Inc. (Nasdaq: EMIS), today announced that its corporate presentation at the
Bank of America Securities Health Care Conference will be webcast live over
the internet. Michael M. Goldberg, M.D., Chairman and Chief Executive Officer,
will present to investors on Wednesday, May 18, 2005, at 1:20 p.m. PDT,
4:20 p.m. EDT. The conference is being held May 17 - 19, 2005 at the Four
Seasons' Hotel, Las Vegas, NV.
    The presentation will be broadcast live via the Internet. You may access
the presentation by visiting the investor relations portion within the
Emisphere Technologies, Inc. web site: http://www.emisphere.com/ir.asp or
directly at http://www.veracast.com/webcasts/bas/healthcare05/id12208209.cfm.
Please visit the site at least five minutes prior to start time for
instructions. A replay will be available through June 3, 2005. Corresponding
slides will also be posted to the investor relations portion of Emisphere's
web site.

    About Emisphere Technologies, Inc.
    Emisphere Technologies, Inc. is a biopharmaceutical company pioneering the
oral delivery of otherwise injectable drugs. Emisphere's business strategy is
to develop oral forms of injectable drugs, either alone or with corporate
partners, by applying its proprietary eligen(R) technology to those drugs or
licensing its eligen(R) technology to partners who typically apply it directly
to their marketed drugs. Emisphere's eligen(R) technology has enabled the oral
delivery of proteins, peptides, macromolecules and charged organics. Emisphere
and its partners have advanced oral formulations or prototypes of salmon
calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and
cromolyn sodium into clinical trials. Emisphere has strategic alliances with
world-leading pharmaceutical companies. For further information, please visit
http://www.emisphere.com.


SOURCE Emisphere Technologies, Inc.




Back to Topback to top

Related links:
  • http://www.emisphere.com
    CONTACT:
    At Emisphere Technologies, Inc. - Gillian
    Racine, Investor Relations, +1-914-785-4762,
    gracine@emisphere.com